Emerging concepts in the management of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma is characterised by poor oncological outcomes with curative treatment only possible for a minority. Symptoms are dependent on the stage of the disease and location within the pancreas with constitutional decline often prominent. Patients require biochemical investiga...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2019-12-01
|
Series: | Laparoscopic, Endoscopic and Robotic Surgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S246890091930043X |
id |
doaj-60f2011476314f7abf32a2043dc07e8a |
---|---|
record_format |
Article |
spelling |
doaj-60f2011476314f7abf32a2043dc07e8a2021-04-02T11:31:36ZengKeAi Communications Co., Ltd.Laparoscopic, Endoscopic and Robotic Surgery2468-90092019-12-01248388Emerging concepts in the management of pancreatic ductal adenocarcinomaSanket Srinivasa0Rowan Parks1HPB Surgery, Royal Infirmary of Edinburgh, Edinburgh, UKHPB Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK; Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK; Corresponding author: HPB Surgery, Royal Infirmary of Edinburgh; Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK.Pancreatic ductal adenocarcinoma is characterised by poor oncological outcomes with curative treatment only possible for a minority. Symptoms are dependent on the stage of the disease and location within the pancreas with constitutional decline often prominent. Patients require biochemical investigations and accurate imaging with CT to determine stage of disease and local resectability. CT-PET and endoscopic ultrasound are increasingly used preoperatively. Surgery remains the cornerstone of curative management and can be performed using minimally invasive approaches. Vascular resection and combination treatment with chemoradiotherapy are also utilised for suitable patients. Perioperative outcomes may be optimised using enhanced recovery pathways. Quality standards have been defined for individual clinicians and units to benchmark their clinical outcomes. The developments described hold promise in improving outcomes from pancreatic ductal adenocarcinoma. Keywords: Pancreatic ductal adenocarcinoma, Pancreatic resection, Laparoscopic surgery, Robotic surgeryhttp://www.sciencedirect.com/science/article/pii/S246890091930043X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sanket Srinivasa Rowan Parks |
spellingShingle |
Sanket Srinivasa Rowan Parks Emerging concepts in the management of pancreatic ductal adenocarcinoma Laparoscopic, Endoscopic and Robotic Surgery |
author_facet |
Sanket Srinivasa Rowan Parks |
author_sort |
Sanket Srinivasa |
title |
Emerging concepts in the management of pancreatic ductal adenocarcinoma |
title_short |
Emerging concepts in the management of pancreatic ductal adenocarcinoma |
title_full |
Emerging concepts in the management of pancreatic ductal adenocarcinoma |
title_fullStr |
Emerging concepts in the management of pancreatic ductal adenocarcinoma |
title_full_unstemmed |
Emerging concepts in the management of pancreatic ductal adenocarcinoma |
title_sort |
emerging concepts in the management of pancreatic ductal adenocarcinoma |
publisher |
KeAi Communications Co., Ltd. |
series |
Laparoscopic, Endoscopic and Robotic Surgery |
issn |
2468-9009 |
publishDate |
2019-12-01 |
description |
Pancreatic ductal adenocarcinoma is characterised by poor oncological outcomes with curative treatment only possible for a minority. Symptoms are dependent on the stage of the disease and location within the pancreas with constitutional decline often prominent. Patients require biochemical investigations and accurate imaging with CT to determine stage of disease and local resectability. CT-PET and endoscopic ultrasound are increasingly used preoperatively. Surgery remains the cornerstone of curative management and can be performed using minimally invasive approaches. Vascular resection and combination treatment with chemoradiotherapy are also utilised for suitable patients. Perioperative outcomes may be optimised using enhanced recovery pathways. Quality standards have been defined for individual clinicians and units to benchmark their clinical outcomes. The developments described hold promise in improving outcomes from pancreatic ductal adenocarcinoma. Keywords: Pancreatic ductal adenocarcinoma, Pancreatic resection, Laparoscopic surgery, Robotic surgery |
url |
http://www.sciencedirect.com/science/article/pii/S246890091930043X |
work_keys_str_mv |
AT sanketsrinivasa emergingconceptsinthemanagementofpancreaticductaladenocarcinoma AT rowanparks emergingconceptsinthemanagementofpancreaticductaladenocarcinoma |
_version_ |
1724164470419226624 |